Methyldopa - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for methyldopa and what is the scope of freedom to operate?

Methyldopa is the generic ingredient in three branded drugs marketed by Merck, Accord Hlthcare, Chartwell Rx, Duramed Pharms Barr, Halsey, Heritage Pharma, Parke Davis, Pliva, Purepac Pharm, Rising, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in fifty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for methyldopa. Two suppliers are listed for this compound.

Summary for methyldopa

US Patents:	0
Tradenames:	3
Applicants:	23
NDAs:	57
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	96
Clinical Trials:	19
Patent Applications:	5,656
Drug Prices:	Drug price trends for methyldopa
What excipients (inactive ingredients) are in methyldopa?	methyldopa excipients list
DailyMed Link:	methyldopa at DailyMed

See drug prices for methyldopa

Recent Clinical Trials for methyldopa

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cairo University	Phase 4
Federal University of Paraíba	Phase 4
Assiut University	Phase 2

See all methyldopa clinical trials

Pharmacology for methyldopa

Drug Class	Central alpha-2 Adrenergic Agonist
Mechanism of Action	Adrenergic alpha2-Agonists

Medical Subject Heading (MeSH) Categories for methyldopa

Adrenergic alpha-2 Receptor Agonists
Antihypertensive Agents
Sympatholytics

US Patents and Regulatory Information for methyldopa

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070291-001	Jul 1, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rising	METHYLDOPA	methyldopa	TABLET;ORAL	070076-002	Apr 18, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	METHYLDOPA	methyldopa	TABLET;ORAL	070333-001	Apr 15, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for methyldopa

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	ALDOMET	methyldopa	SUSPENSION;ORAL	018389-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.